[The seroprevalence of human immunodeficiency virus infection (HIV) in patients with tuberculosis at the National Hospital of Niamey, Niger (1990-1991)] NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[The seroprevalence of human immunodeficiency virus infection (HIV) in patients with tuberculosis at the National Hospital of Niamey, Niger (1990-1991)]

Bull Soc Pathol Exot. 1995;88(3):121-3. Unique Identifier : AIDSLINE MED/96150686
Ousseini H; Kim DS; Adamou A; Faculte des Sciences de la Sante, Niamey, Niger.

Abstract: This study has been planned in order to determinate the frequency of the infection by VIH among the 394 new tuberculous, for a period extended from July 1990 to July 1991 at the section of pneumophtisiology in the National Hospital of Niamey. The number of seropositives is 7.6%. The two types of viruses, i.e. VIH1 and VIH2, and the double infection by VIH1 + VIH2 types exist in the tuberculous patients. The VIH1 is most frequently found in the subjects of age group 20-39 years, who are almost emigrants. Inspite of the actual weak sero-prevalency among the tuberculous patients, the authors claim that a sero-epidemiological sequential survey of tuberculosis in Niamey can be a relatively easy method for measuring the variations of sero-prevalency of AIDS in Niger.
Keywords: Acquired Immunodeficiency Syndrome/EPIDEMIOLOGY Adult AIDS-Related Opportunistic Infections/EPIDEMIOLOGY Emigration and Immigration English Abstract Female Human HIV Infections/EPIDEMIOLOGY *HIV Seroprevalence HIV-1/ISOLATION & PURIF HIV-2/ISOLATION & PURIF Male Niger/EPIDEMIOLOGY Tuberculosis, Pulmonary/*EPIDEMIOLOGY JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/epidemiologyadultaids-relatedopportunisticinfections/epidemiologyemigrationandimmigrationenglishabstractfemalehumanhivinfections/epidemiologyKWDhivseroprevalencehiv-1/isolation&purifhiv-2/isolation&purifmaleniger/epidemiologytuberculosis,pulmonary/KWDepidemiologyjournalarticle
960530
M9651053

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .